All-in-one event platform optimized for connecting
Bridging the Frontiers of Care
The only product clinically proven to protect and restore the endothelial glycocalyx — for improved cardiovascular health and blood flow.
Calroy Health Sciences’ mission is to develop innovative therapies in the emerging field of the vascular endothelial glycocalyx (EG) and cardiovascular health. The focus of the company’s research and product development efforts target the protection of the endothelium. Arterosil is the only product clinically proven to protect and restore the endothelial glycocalyx.
Video Library
The Endothelial Glycocalyx: A Critical Role in Vascular Health
Immunity and the Endothelium
The Endothelial Glycocalyx & COVID-19
Arterosil: Hypertension Study Results
Arterosil: Stubborn Plaque Cases
Calroy Health Sciences is committed to developing vascular health educational programs to keep practitioners informed on the latest news and clinical science.
Subscribe HereSubscribe to the Arterosil educational newsletter
Learn, Grow, Read
Our practitioner educational newsletter highlights the latest research, clinical how-tos and protocols, as well as upcoming webinars and educational events.
Sign Up